Biotech4 years ago
GSK, Lilly and Vir Biotechnology achieve positive results in Phase II COVID-19 study
GSK, Lilly, and Vir Biotechnology have recently presented the results of a COVID-19 study. The two monoclonal antibodies in combination have demonstrated a 70% relative reduction...